The objective of this study is to determine if, compared to placebo, zonisamide (400mg/day)
is a safe and efficacious treatment for post-traumatic stress disorder (PTSD) and alcohol use
disorder (AUD) in Veterans with PTSD and co-occurring AUD.
Phase:
Phase 2
Details
Lead Sponsor:
Pharmacotherapies for Alcohol and Substance Abuse Consortium
Collaborators:
Baylor College of Medicine Congressionally Directed Medical Research Programs Michael E. DeBakey VA Medical Center